TableĀ 2

Genetic results and survival information

PatientBiopsy specimen genetic testBiopsy specimenSecondary solid specimen genetic testSecondary solid specimenPatient status
Chr3Chr8qChr6pChr3Chr8qChr6p
1MLPALNGMLPALNGA
2MSANMLPANNGA
3MSALMLPALNND*
4MLPALGUMLPALGNA
5MSALMLPALGUD
6MSALMLPALGUA
7MSALMLPALGNA
8MSANMLPANGGA
9MLPANNGMLPANNGA
10MSANMLPANGGA
11MSANMLPANGGA
12MSANMLPANNGA
13MLPANGGMLPANGGA
14MLPANNGMLPANNGA
15MSANMLPANNNA
16MLPALGNMLPALGNA
17MSALMLPALGUA
18MLPANNNMLPANNNA
19MLPALGNMLPALGNA
20MLPAPartial L (3p)GNMLPALGNA
21MLPANNUMLPANNNA
22MSAPartial L (3q)MLPAPartial L (3q)NNA
23MLPALNGMLPALNLA
24MSALMLPALNNA
25MSALMLPALGGA
26MLPAPartial L (3q)GGMLPAPartial L (3q)GGA
27MLPANGGMSANA
28MLPALGNMLPALGGA
  • *Death from non-CM related metastatic disease.

  • A, alive; CM, choroidal melanoma; D, dead; G, gain; L, loss; MLPA, multiplex ligation dependent probe amplification; MSA, microsatellite analysis; N, normal diploid copy number; U, unclassified.